Study Sparks Renewed Discussion on Cell Phone Radiation Safety
Despite some health organizations claiming that radiofrequency radiation is harmless, a new study suggests that prolonged exposure may damage human cells.
Cell phones have only been part of our lives for a few decades, yet they have become indispensable tools for everything from paying bills to streaming videos. However, their convenience comes with controversy as concerns rise over the effects of the radiofrequency radiation (RFR) they emit.
While health organizations say this non-ionizing radiation is harmless, a recent study, which the authors describe as the first controlled human intervention trial examining the cytotoxic effects of cell phone radiation, suggests that prolonged exposure may damage human cells.
The Cancer Controversy
For cell phones to work their magic—transmitting conversations and data without wires—they are designed to emit a field of radiofrequency radiation (RFR). This is the same microwave radiation that powers radar systems and microwave ovens, although cell phones broadcast at a much lower intensity.
However, several human studies indicate that mobile phone-specific electromagnetic fields may cause cancer. Based on this evidence, in May 2011, a committee for the World Health Organization’s (WHO) International Agency for Research on Cancer (IARC) determined that cell phone radiation is “a possible human carcinogen.”
The New Evidence
A 2024 study published in Environmental Research shows evidence of cell toxicity linked to cell phone radiation, leading scientists to ponder its potential long-term health implications.
For two hours a day over five consecutive days, 41 participants in the study wore headsets that broadcast a third-generation mobile cellular signal (commonly known as 3G—a network standard that has been around since 2001 because it enables a wireless internet connection). Exposure to the signal was randomly assigned to one side of the head.
Before the trial and three weeks after the exposure, scientists collected cells from the cheeks on both sides of each subject’s head.
On the side of the head exposed to the 3G radiation, researchers found a significant increase of binucleated cells (cells formed as a consequence of disturbed cell divisions) and evidence of cell death. No such effects were observed in cells from the side of the head that was not exposed to the 3G signal.
Researchers say the study is significant because it is the first controlled human intervention trial examining the cytotoxic effects of cell phone radiation (previous research measured effects on mice).
Researchers point to accumulating evidence that exposure to RFR is associated with specific brain tumors. Their results indicate that molecular mechanisms other than chromosomal damage may cause cell damage, a key factor in the development of cancer. The researchers posit that the results they observed may be due to either an inflammatory response and/or the release of free radicals.
The Epoch Times contacted the U.S. Food and Drug Administration (FDA) to see how consumers should consider this research. In an email, Jim McKinney, press officer with the agency, said, “The FDA does not comment on specific studies, but evaluates them as part of the body of evidence to further our understanding about a particular issue and assist in our mission to protect public health.”
A spokesperson for the IARC said they had no one available to comment.
Experts Divided
Since the IARC’s evaluation of cell phone radiation as a potential cause of cancer more than a decade ago, the agency has been repeatedly urged by its scientific panel to examine newly available research. In 2019 and again this year, the scientific panel advising the IARC suggested that studying cancer risks associated with cell phone radiation should be “high priority.”
Major US Study Links Cell Phone Radiation to Cancer in Rats
The push for IARC to reexamine RF radiation comes in large part from a major study from the U.S. government. In 2018, the final report of a $30 million, 10-year study funded by the FDA and conducted by the National Toxicology Program (NTP)—the federal agency tasked with testing toxins—showed “clear evidence of cancer and DNA damage” linked to cell phone use in male rats.
The study looked at both 2G and 3G radiation. It revealed an association with malignant tumors in the hearts and brains of male rats, as well as some evidence of an association with tumors in the adrenal glands of male rats.
What does this mean for the average human with a smartphone?
- The exposure levels were greater than what people may receive from cell phones.
- Rats were exposed to radiofrequency radiation across their whole bodies, which is different from a person carrying a cell phone in their pocket or using it next to their head.
However, NTP researchers noted that their study calls into question “the long-held assumption that RFR is of no concern as long as the energy level is low and does not significantly heat the tissues.”
FDA Recently Cast Doubt on NTP Study
Regulators have also questioned the NTP study’s conclusion. An article by the FDA, current as of May 2024, notes that:
- Unlike human cell phone users, rats in the NTP study received radiation over their entire bodies.
- Rats also received this whole-body radiation for nine hours per day for their entire lives.
According to the article, the rats received radiation levels up to “75 times higher than the whole-body exposure limit for people.” The FDA notes that the study found “no health effects on female rats or mice (both male and female) exposed to these extreme conditions that passed a test for statistical significance.” Finally, despite the tumors, exposed rats lived longer than their control group counterparts.
The FDA also noted that cancer rates in the United States haven’t increased despite widespread cell phone use over the last 30 years. In fact, brain and nervous system cancer rates have actually decreased between 2002 and 2019, according to the FDA, which cited The Pew Research Center estimates.
Push for a Follow Up
A push for a follow-up NTP study persists.
“There are always experimental uncertainties in in vivo studies of live animals, and definitive conclusions cannot be drawn from a single trial, regardless of its scale,” the researchers wrote. “Moreover, animal studies with poor reproducibility cannot be considered objective scientific evidence.”